The research incentive scheme for companies (RISC) grant is intended to encourage the development of strategic technologies and capabilities in Singapore. CombinatoRx Singapore plans to use this grant
The combination of SCV-07 with the BCG vaccine resulted in a significantly superior protective effect against mycobacterium tuberculosis, the bacteria that cause TB, compared with the administration of
The product, initially developed by SkyePharma, was licensed to Endo in December 2002. The UK company said that it is now evaluating its options worldwide for this product.
Androgen deprivation therapy (ADT) lowers levels of male hormones and can cause prostate cancer tumors to shrink or grow more slowly, however the treatment is associated with several
The company's total revenues were up 11% to $667.5 million and product sales up 7.9% to $594.9million. This was driven by strong sales of the company's multiple sclerosis
The increased bid of HRK630 in cash per share represents an 11% increase on the previous bid of $1.6 billion that Actavis made last month. Pliva said in
Folate receptors are commonly found on the surface of many types of tumor cells, but they are relatively rare in most non-cancerous tissue. By combining folate with anticancer
SCH 503034 is being evaluated in a large phase II study in combination with peg-intron (peginterferon alfa-2b) for the treatment of patients chronically infected with hepatitis C virus
MedImmune will combine its expertise in monoclonal antibodies with Elusys’ proprietary heteropolymer (HP) antibodies. Under the terms of the agreement, Elusys will receive an undisclosed upfront payment, milestone
The phase I study examined the safety and tolerability of single and multiple doses of orally-administered ILY101 in twenty-four healthy volunteers. With the successful completion of phase I,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.